Carlos Dzik

Sao Paulo, SP, BR 
Sao Paulo, SP, BR 

Overview

Carlos Dzik practices practicing medicine in Sao Paulo, Brazil.

His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, and Testicular Cancer.

He is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Sao Paulo, SP, Brazil
Other Locations
Porto Alegre, RS, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Multicenter Database of Patients With Germ Cell Tumor in Order to Characterize Clinicopathologically and to Evaluate Cancer Treatment Outcomes
Multicenter Database of Patients With Germ Cell Tumor in Order to Characterize Clinicopathologically and to Evaluate Cancer Treatment Outcomes
Enrollment Status: Completed
Publish Date: December 27, 2021
Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)
Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)
Enrollment Status: Unknown
Publish Date: August 26, 2021
Intervention Type: Drug
Study Drug: Nivolumab
Study Phase: Phase 2
Biomarker Study of Patients With Metastatic Clear Cell Renal Carcinoma (ccRCC) Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib
Biomarker Study of Patients With Metastatic Clear Cell Renal Carcinoma (ccRCC) Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib
Enrollment Status: Unknown
Publish Date: September 04, 2019
Intervention Type: Drug
Study Drug: Sunitinib
Study Phase: Phase 2
View 2 Less Clinical Trials

16 Total Publications

Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer.
Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer.
Journal: Pathology, research and practice
Published: November 14, 2024

Frequently Asked Questions about Carlos Dzik

Is Carlos Dzik a top-rated expert for Renal Cell Carcinoma (RCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Carlos Dzik is classified as an Experienced expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Carlos Dzik participate in research or clinical trials?

Yes. Carlos Dzik has published 16 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Carlos Dzik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dzik's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile